|
|
|
Volumn 4, Issue 2, 1998, Pages 148-154
|
|
Glutamate antagonists, steroids, and antioxidants as therapeutic options for hearing loss and tinnitus and the use of an innear ear drug delivery system
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE;
ALPRAZOLAM;
AMFEBUTAMONE;
AMINOOXYACETIC ACID;
AMITRIPTYLINE;
AMOBARBITAL;
ANESTHETIC AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ANTIOXIDANT;
ANXIOLYTIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
CHLOROTHIAZIDE;
CHLORPHENIRAMINE;
CLONAZEPAM;
DIAZEPAM;
DIHYDROERGOTOXINE MESILATE;
DIMETHYL SULFOXIDE;
DIURETIC AGENT;
FLECAINIDE;
FLECAINIDE ACETATE;
FLUNARIZINE;
FLUOXETINE;
FLURAZEPAM;
GLUTAMATE RECEPTOR ANTAGONIST;
LIDOCAINE;
MECLOZINE;
MEXILETINE;
NICOTINIC ACID;
NIMODIPINE;
NOVOCAIN IV;
OXAZEPAM;
PAROXETINE;
PRIMIDONE;
PROCAINE;
PROSTAGLANDIN;
PROTRIPTYLINE;
SERTRALINE;
STEROID;
TERFENADINE;
TOCAINIDE;
TRIMIPRAMINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VASOACTIVE AGENT;
XYLOCAINE IV;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
DRUG DELIVERY SYSTEM;
HEARING LOSS;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
NEUROTOXICITY;
NONHUMAN;
POPULATION RESEARCH;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RAT;
TINNITUS;
UNITED STATES;
|
|
EID: 0032323748
PISSN: 09465448
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (42)
|
|
References (42)
|
